Epigenetics, I GF2 dosage and cancer risk

Kaneda, Feinberg, Iacobuzio-Donahue, Takashi Sakatani, Sten De Boom Witzel, Mark Carter, Minoru Ko, Dan Longo, Hideyuki Okano, Ohlsson

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalCancer Biology and Therapy
Volume4
Issue number3
Publication statusPublished - 2005 Mar 1

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Kaneda, Feinberg, Iacobuzio-Donahue, Sakatani, T., Witzel, S. D. B., Carter, M., Ko, M., Longo, D., Okano, H., & Ohlsson (2005). Epigenetics, I GF2 dosage and cancer risk. Cancer Biology and Therapy, 4(3).